| Title |
Recent insights into cigarette smoking as a lifestyle risk factor for breast cancer
|
|---|---|
| Published in |
Breast cancer targets and therapy, March 2017
|
| DOI | 10.2147/bctt.s129746 |
| Pubmed ID | |
| Authors |
Shannon Kispert, Jane McHowat |
| Abstract |
There have been many cohort studies published reviewing the epidemiological evidence that links breast cancer to cigarette smoking, yet the underlying mechanisms are largely unknown and research studies are few and incomplete. Although cohort studies are important in establishing a connection between breast cancer and cigarette smoking, basic science research is necessary to prove the relationship and to highlight potential interventions and drug targets that can be used to manage the disease. This subject has been controversial for many decades; however, there has been a recent resurgence in interest because of the widespread acknowledgment of the role lifestyle choices play in cancer development and progression. This review will detail the current statistics associated with cigarette smoking and discuss recent cohort and basic research studies that highlight the association of cigarette smoking and breast cancer initiation and progression. |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 5 | 33% |
| United States | 2 | 13% |
| Venezuela, Bolivarian Republic of | 1 | 7% |
| Jordan | 1 | 7% |
| Unknown | 6 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 93% |
| Practitioners (doctors, other healthcare professionals) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 227 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 227 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 45 | 20% |
| Student > Master | 27 | 12% |
| Student > Ph. D. Student | 22 | 10% |
| Researcher | 12 | 5% |
| Student > Postgraduate | 10 | 4% |
| Other | 32 | 14% |
| Unknown | 79 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 33 | 15% |
| Biochemistry, Genetics and Molecular Biology | 32 | 14% |
| Nursing and Health Professions | 31 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 5% |
| Agricultural and Biological Sciences | 8 | 4% |
| Other | 24 | 11% |
| Unknown | 87 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2021.
All research outputs
#1,856,691
of 25,584,565 outputs
Outputs from Breast cancer targets and therapy
#17
of 326 outputs
Outputs of similar age
#35,271
of 324,971 outputs
Outputs of similar age from Breast cancer targets and therapy
#3
of 24 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 326 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,971 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.